(4045-301) A 48-Week, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients with Duchenne Muscular Dystrophy

Project: Research project

Project Details

StatusActive
Effective start/end date11/1/15 → 8/31/50

Funding

  • Sarepta Therapeutics, Inc.